{"id":769466,"date":"2018-01-23T15:00:21","date_gmt":"2018-01-23T13:00:21","guid":{"rendered":""},"modified":"2018-02-08T11:52:35","modified_gmt":"2018-02-08T09:52:35","slug":"zatverdzheno-novyj-reyestr-likarskyh-zasobiv-vartist-yakyh-pidlyagaye-vidshkoduvannyu","status":"publish","type":"post","link":"https:\/\/new.eba.com.ua\/en\/zatverdzheno-novyj-reyestr-likarskyh-zasobiv-vartist-yakyh-pidlyagaye-vidshkoduvannyu\/","title":{"rendered":"A New Register of Medicines Subject to Reimbursement Approved"},"content":{"rendered":"<p>Within the government reimbursement program &#8220;Affordable Medicines&#8221;, based on the results of consideration of applications of manufacturers, which were accepted from January 2<sup>nd<\/sup>, 2018 to January 11<sup>th<\/sup>, 2018, Order of the Ministry of Health of Ukraine No. 111 as of January 22<sup>nd<\/sup>, 2018 approved an updated Register of Medicines Subject to Reimbursement.<\/p>\n<p>The Register contains 239 items of medicines for the treatment of cardiovascular diseases, diabetes of type II and bronchial asthma, which is 41 more than in the previous one.<\/p>\n<p>Therefore Order of the Ministry of Health of Ukraine No. 856 as of July 26<sup>th<\/sup>, 2017 has expired.<\/p>\n<p>The updated Register of Medicines Subject to Reimbursement has been approved taking into account the following:<\/p>\n<p>On December 27<sup>th<\/sup>, 2017 the Government adopted changes to the &#8220;Affordable Medicines&#8221; program, supplementing it with two new active substances for the treatment of cardiovascular diseases and diabetes of type 2 &#8211; Lozartan and Glibenclamide.<\/p>\n<p>Order of the Ministry of Health of Ukraine No. 2 as of January 2<sup>nd<\/sup>, 2018 approved a new register of ex-factory prices for medicines.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Within the government reimbursement program &#8220;Affordable Medicines&#8221;, based on the results of consideration of applications of manufacturers, which were accepted from January 2nd, 2018 to January 11th, 2018, Order of [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":75156,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[15576,15575],"tags":[],"class_list":["post-769466","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-and-articles-en","category-news-and-articles-from-companies-en","company-16134"],"_links":{"self":[{"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/posts\/769466","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/comments?post=769466"}],"version-history":[{"count":0,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/posts\/769466\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/media\/75156"}],"wp:attachment":[{"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/media?parent=769466"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/categories?post=769466"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/tags?post=769466"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}